More details
Fact Sheet
Pulmonary Embolus (PE)

Pulmonary Embolus (PE)*


Overview

A pulmonary embolus (PE) occurs when a blood clot enters the blood vessels (arteries) of the lung. PE often occur when a blood clot that starts in the veins of the legs travels to the blood vessels in the lungs. Sometimes PE can occur without any blood clot found in the leg.

What is the problem with PE?

Pulmonary Embolus (PE) can be life threatening

This is because the blood supply to the lungs is essential for oxygenation of the blood. Blood flow to the lung can stop if the blood clot is big enough to block one of the main arteries supplying the lung. This can lead to low blood flow around the rest of the body which can lead to collapse and even death. Smaller blood clots can lead to poor lung function and reduced oxygenation of the blood.

How is a pulmonary embolus diagnosed?

A PE is usually diagnosed by special x-rays (CT scan) that identify the blood clot blocking the blood vessel in the blood vessels of the lungs. Other techniques use special radioactive dye to look at the blood flow of the lungs. Additional tests that may be helpful include blood tests and tracings of the rhythm of the heart (ECG).

Why did I develop a pulmonary embolus?

Usually people get PE for the same reason blood clots occur in other parts of the body. Some factors for getting a blood clot in the body include:

  • Hospitalisation for a medical illness
  • Recent major surgery or injury
  • Previous history of DVT / PE
  • Known personal history or a family history of a clotting disorder
  • History of active cancer and concurrent cancer therapy
  • Pregnancy and first 6 weeks after delivery
  • Smoking
  • Hormone replacement therapy or high dose combined oral contraceptive pill
  • Being overweight or obese
  • Prolonged sitting (greater than 6 to 8 hours)

How is a pulmonary embolus treated?

A PE is treated with blood thinning (anticoagulation).

Anticoagulation is important to prevent any further blood clots from developing and may also assist in reducing the size of blood clots that have already formed. If the blood clot is particularly large and blocking a lot of blood flow to the lung, a special medication given by the intravenous drip can be given to dissolve the blood clot. This medication (called lytic therapy) needs to be given in hospital and is associated with a significant risk of bleeding.

Often blood thinning can be started and continued to be given as an outpatient with injections under the skin (low molecular weight heparin – Clexane). Patients will usually then need to start on tablets (Warfarin) XXXX and continue anticoagulation treatment.

How long will I need to be on anticoagulation (blood-thinning) medication for?

This will depend on why you develop the blood clot in the first place. If the blood clot occurred in the setting of surgery or a known risk factor that is no longer present you may need six months blood thinning.

If a risk factor is not identified and your doctor thinks you may be at risk of developing further PE, a longer period of blood thinning may be needed.

Some people stay on blood thinning for a very long time because of they have a high risk of developing further PE. It is important for you to discuss this with your doctor.

Dummy Image

HS is relatively common – around 1 person in every 5000 people has HS (around 800 people in Melbourne; population 4 million).

0

in 5000 people has HS

Which is the same as

0

people in Melbourne

0

population of Melbourne*


What does having HS mean?

There are three main common problems associated with having HS:

01.

Anaemia

– this occurs because the red cells break down more quickly

02.

Jaundice

– when red cells break down they release a pigment called bilirubin which appears as a yellow colour in the skin and the eyes. Over a long period of time, the problem of jaundice can be associated with gall stones.

03.

Increase in the size of the spleen

– this is the site of the red cells breaking down. The spleen is a blood filter and some of the red cells can get caught up in the spleen

There is another uncommon potential problem for people who have Hereditary Spherocytosis associated with a viral infection called “Slapped cheek”. Slapped cheek is caused by a virus called Parvovirus which can infect bone marrow cells and put the red cell producing cells “to sleep”. Because patients with HS need the bone marrow to be rapidly replacing the fragile red cells, this infection can cause a severe anaemia; patients can become very pale and sometimes even require blood transfusions. Fortunately this problem is uncommon.


Diagnosis

How is Hereditary Spherocytosis diagnosed?

HS is now diagnosed with a simple blood test. It is also important for a doctor to examine patients with HS to see if they are jaundiced or have an increase in the size of the spleen.


Treatment & Management

What do I need to do now that I (or my child) has been diagnosed with Hereditary Spherocytosis?

Most patients with HS do not need to do much about their condition at all. The bone marrow has the capacity to increase the number of red cells it produces many fold and is able to keep up replacing the fragile cells.

A few things may be helpful:

01.

Regular blood tests

– to check on the level of haemolysis

02.

Folate supplementation

An important vitamin necessary for the bone marrow to function properly is folate. Folate is found in green leafy vegetables. Most people get enough folate in their diet but getting extra folate (particularly in HS if there is significant haemolysis – red cell breakdown) is generally recommended.

03.

Ultrasounds to exclude gall stones

It may also be important to make sure children and adults are not developing gall stones – an ultrasound of the gall bladder after that age of 5 years of age every 3 – 5 years there after, is the current recommendation.

Will I (or my child) need a splenectomy?

Removing the spleen (splenectomy) has been used a lot in the past in the treatment and management of patients with HS; it stops the red cells from breaking down and solves the problems of HS.

Removing the spleen has problems however – the spleen is an important organ in the immune system and patients who do not have a spleen may be prone to getting serious infections. This risk is higher in younger children but may be less than previously expected because of newer vaccinations. It is now generally recommended to avoid splenectomy in children younger than 6 years and to ensure that children who may need a splenectomy have all the appropriate vaccinations.

Another approach for some of these young patients is to remove only a small part of the spleen – partial splenectomy. This is done in a few hospitals and there is some experience to say this may be very helpful for some patients.


Resources used to produce this information sheet.

  1. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. Feb 2012;141(2 Suppl):7S-47S.


Further Questions?

The information presented in this fact sheet is intended as a general guide only.

Patients should seek further advice and information about Pulmonary Embolus (PE) and their individual condition from their treating haematologist or doctor.

1000 563 Melbourne Haematology
Start Typing
Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

For performance and security reasons we use Cloudflare
required
Our website uses cookies, mainly from 3rd party services. Define your Privacy Preferences and/or agree to our use of cookies.